Class Action Roundup With Scott Hardy | Feb. 8-12

Are you owed some money?

Top Class Actions founder and president Scott Hardy breaks down this week’s top class action lawsuits and settlements you should know about!

Robinhood Draws Multiple Class Actions Over GameStop Frenzy

Amid chaos attributed to Reddit users, at least five class action lawsuits have been launched against the Robinhood app, TD Ameritrade and Charles Schwab.

Plaintiffs in the class action lawsuits allege Robinhood traders were blocked from purchasing stock in GameStop and other companies in an attempt to calm price volatility.

TD Ameritrade and Charles Schwab also allegedly blocked certain trades.

The plaintiffs accuse the brokers of illegally favoring wealthy hedge funds and of breach of contract.

According to the complaints, the defendants barred traders from GameStop to help keep major hedge funds from losing money at investors’ expense.

Read more about the Robinhood class action lawsuits here.

Subway’s Tuna Sandwiches Contain No Actual Tuna, Class Action Lawsuit Asserts

No tuna in Subway’s tuna subs? 

That’s what a $5 million class action lawsuit alleges.

According to the complaint, testing revealed Subway’s tuna to be a mix of various things that look similar to tuna, but isn’t actually tuna – and may not even be seafood.

The plaintiffs say “they were tricked into buying food items that wholly lacked the ingredient they reasonably thought they were purchasing.” 

Subway stands accused of breaking several laws.

If the case proceeds as a class action, the Class could number in the thousands.

Get more info here!

Do You Qualify: Booster Seat False Safety Tests Class Action Investigation

A December 2020 U.S. House of Representatives subcommittee report revealed certain child vehicle booster seat manufacturers might be misleading consumers about the products’ safety.

The subcommittee found the manufacturers failed to conduct proper side-impact testing and deceived consumers by making false and misleading statements about the “meaningless safety tests” they conducted.

The report says the manufacturers knew the booster seats weren’t safe for toddlers weighing less than 40 pounds but continued to market them for use by children weighing as little as 30 pounds.

Brands such as Graco, Evenflo, Britax, and Baby Trend were included in subcommittee’s investigation.

Read more here.

Credit One TCPA Class Action Claims ‘Aggravation, Annoyance’

A recent class action lawsuit claims Credit One bank placed unwanted marketing calls to consumers in violation of the Telephone Consumer Protection Act (TCPA).

The lead plaintiff in the class action lawsuit claims Credit One called her repeatedly without permission using pre-recorded marketing messages.

The calls allegedly continued even after the plaintiff asked Credit One to stop calling her.

According to the complaint, the use of automatic dialing systems and pre-recorded messages is illegal under state and federal law.

The plaintiff is seeking to represent a nationwide Class of people who received these types of calls from Credit One and is asking for damages in the amount of $500 per unwanted call placed to Class Members.

Click here for more on this case.

Aldi Faces Heat From Buyers Over Alleged ‘Not Smoked’ Cheddar

Aldi allegedly hides the true nature of the smoked cheese products it sells, a recent class action lawsuit claims.

According to the plaintiff, Aldi’s Smoked White Cheddar Deli Sliced Cheese is not smoked at all, but is instead flavored using liquid smoke.

This is misleading to shoppers expecting to purchase the real thing, the class action lawsuit says.

The complaint states the U.S. Food and Drug Administration (FDA) requires products using liquid smoke flavor to be declared on the front label. The Aldi cheese allegedly does not meet this requirement.

 Read more here.

Valsartan Manufacturers to Face Consumer Fraud Claims

A judge has ruled valsartan manufacturers must face claims of fraud over the contamination of the blood-pressure drug.

The valsartan multidistrict litigation (MDL) challenges several companies’ roles in contaminating blood-pressure medicines.

According to the plaintiffs, pharmaceutical companies should have included N-Nitrosodimethylamine (NDMA) on the labels of their valsartan products.

They also argue blood-pressure medications that contain NDMA-contaminated valsartan expose them to increased cancer risk.

Manufacturers should have known earlier about this contamination, the plaintiffs say.

The judge presiding over the case determined the plaintiffs had established the drug manufacturers failed to inform consumers of the contamination.

Find out more here.